ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Scemblix 100 mg, Filmtabletten - 120
68441005 Novartis Pharma Schweiz AG
Scemblix 100 mg, Filmtabletten09.06.2022
  12.05.2025
(L01EA06) 
WHO-DDD08.06.2027
07.16.10.120
07.16. 
A  
No 
IP 
PR  
k.A.PR
  
7680684410055Synthetika
  
Composition
asciminibum 100 mg ut asciminibi hydrochloridum 108.1 mg, lactosum monohydricum 215.55 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), E 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, E 172 (rubrum), E 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 2.33 mg.
Packungsbestandteile
Coated tablets
 
Active AgentDose
 100 mg
 
Inactive agentsDoseadditional_information
   
   
   
   
  color.
  color.
   
Lactose Monohydrate215.55 mg 
Lecithine  
   
   
   
Silica Colloidalis Anhydrica  
Talcum  
   
Source
Data was imported : 06.06.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home